세계의 재조합 세포 배양 보충제 시장 - 업계 분석, 규모, 점유율, 성장, 동향 및 예측(2031년) : 제품별, 용도별, 원료별, 최종 사용자별, 지역별

Recombinant Cell Culture Supplements Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region:

US $ 4,995 ￦ 7,057,000

Unprintable PDF & Excel (Single User License)

PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며 텍스트의 Copy&Paste도 불가능합니다.

US $ 8,495 ￦ 12,003,000

Unprintable PDF & Excel (Multi User License upto 5 users)

PDF 및 Excel 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 텍스트는 Copy & Paste 가능하지만, 인쇄는 불가능합니다.

US $ 10,600 ￦ 14,977,000

Printable PDF & Excel (Enterprise License above 5 users)

PDF 및 Excel 보고서를 동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용자수는 5명 이상이며 제한은 없습니다. Copy & Paste 및 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계의 재조합 세포 배양 보충제 시장 규모는 대폭적인 성장을 이루고 있으며, 2024년 말까지 매출은 약 4억 9,900만 달러에 달할 것으로 보입니다. 이 시장은 2031년 말까지 9억 4,000만 달러에 이를 전망입니다.

재조합 세포 배양 보충제는 바이오프로세스, 유전자 치료 및 줄기세포 연구에서 매우 중요한 역할을 합니다. 이 보충제는 줄기 세포의 분화 및 배양의 확장을 지원하기 위해 필수적인 영양소와 성장 인자를 제공합니다. 특히 포유류 세포는 기초 배지 이외에 단백질, 탄수화물, 비타민, 아미노산 등의 추가 물질이 필요합니다.

최근, 재조합 세포 배양 보충제 수요가 현저하게 급증하고 있습니다. 종양학과 줄기세포 연구의 대두가 제조업체에 새로운 기회를 가져오고 있습니다. 재조합 제품은 성장 인자와 보충제의 비용 효율적인 대량 생산과 같은 이점을 제공합니다. 재조합 DNA 기술의 출현은 의약품 개발 및 연구 지원에 대한 제약 업계의 접근 방식을 변경했습니다.

첨단 치료제와 생물 의약품(생물 제제)의 도입은 재조합 세포 배양 보충제 시장의 상당한 성장으로 이어지고 있습니다. 생물제제와 동물을 사용하지 않는 제품에 대한 수요는 향후 수년간 바이오의약품 분야의 큰 변화를 촉진할 것으로 예상됩니다.

암 및 기타 만성 질환의 이환율 증가도 재조합 세포 배양 보충제 시장의 성장에 기여합니다. 세계보건기구(WHO)에 따르면 암은 세계적으로 두 번째로 많은 사인이 되고 있습니다. 이러한 만성 질환의 부담 증가는 효과적인 세포 배양의 개발을 목적으로 하는 연구개발(R&D) 프로젝트에 대한 지출을 촉진할 것으로 예상됩니다.

줄기세포 연구는 계속 확대되고 있으며 줄기세포 치료가 인기를 끌고 있습니다. 재조합 세포 배양 보충제는 세포 요법의 임상 개발을 촉진하기 위해 점점 더 많이 사용되고 있으며, 이로 인해 시장이 활성화되고 있습니다.

본 보고서에서는 세계의 재조합 세포 배양 보충제 시장을 조사했으며, 시장 개요와 함께 제품별, 용도별, 원료별, 최종사용자별, 지역별 동향 및 시장 진출기업의 경쟁 동향 등을 제공합니다.

목차

제1장 주요 요약

제2장 시장 개요

• 시장 정의 및 세분화
• 시장 역학
• 밸류체인 분석
• Porter's Five Forces 분석
• COVID-19의 영향 분석
• 우크라이나와 러시아의 분쟁의 영향
• 경제 개요
• PESTLE 분석

제3장 세계의 재조합 세포 배양 보충제 시장 전망(2018-2031년)

• 세계의 재조합 세포 배양 보충제 시장 전망 : 제품별, 금액(100만 달러)(2018-2031년)
• 세계의 재조합 세포 배양 보충제 시장 전망 : 용도별, 금액(100만 달러)(2018-2031년)
• 세계의 재조합 세포 배양 보충제 시장 전망 : 원료별, 금액(100만 달러)(2018-2031년)
• 세계의 재조합 세포 배양 보충제 시장 전망 : 최종 사용자별, 금액(100만 달러)(2018-2031년)
• 세계의 재조합 세포 배양 보충제 시장 전망 : 지역별, 금액(100만 달러)(2018-2031년)

제4장 북미의 재조합 세포 배양 보충제 시장 전망(2018-2031년)

제5장 유럽의 재조합 세포 배양 보충제 시장 전망(2018-2031년)

제6장 아시아태평양의 재조합 세포 배양 보충제 시장 전망(2018-2031년)

제7장 라틴아메리카의 재조합 세포 배양 보충제 시장 전망(2018-2031년)

제8장 중동 및 아프리카의 재조합 세포 배양 보충제 시장 전망(2018-2031년)

제9장 경쟁 구도

• 원료별 및 용도별 히트맵
• 제조업체 및 용도별 히트 맵
• 기업의 시장 점유율 분석(2023년)
• 경쟁력 대시보드
• 기업 프로파일
  • Merck, KGaA
  • Thermo Fisher Scientific
  • Lonza Group AG
  • F. Hoffmann-La Roche
  • Abcam PLC.
  • Hi-Media Laboratories
  • Becton, Dickinson and Company
  • Fujifilm Corporation
  • STEMCELL Technologies Inc.
  • InVitria
  • Biocon
  • Cell Sciences, Inc.

제10장 부록

AJY

영문 목차

영문목차

The global Recombinant Cell Culture Supplements Market has witnessed substantial growth, with revenues reaching approximately US$ 499 million by the end of 2024. The market is expected to reach a valuation of US$ 940 million by the close of 2031, as indicated by a recent study conducted by Fairfield Market Research.

Key Market Insights

Applications in Bioprocesses, Gene Therapy, and Stem Cell Research

Recombinant cell culture supplements play a pivotal role in bioprocesses, gene therapy, and stem cell research. These supplements provide essential nutrients and growth factors to support stem cell differentiation and culture expansion. In particular, mammalian cells require additional substances, including proteins, carbohydrates, vitamins, and amino acids, in addition to the basal medium.

Growing Demand for Recombinant Products

In recent years, the demand for recombinant cell culture supplements has surged significantly. The rise of oncology and stem cell research has created new opportunities for manufacturers. Recombinant products offer advantages such as cost-effective mass production of growth factors and supplements. The advent of recombinant DNA technology has transformed the pharmaceutical industry's approach to drug development and research support.

Emergence of Advanced Therapeutics and Biopharmaceuticals

The introduction of advanced therapeutics and biopharmaceuticals, or biologics, has led to substantial growth in the recombinant cell culture supplements market. The demand for biologics and animal-free products is expected to drive significant changes in the biopharmaceutical sector in the coming years.

Increasing Incidence of Chronic Diseases

The rising incidence of cancer and other chronic diseases has also contributed to the growth of the recombinant cell culture supplements market. According to the World Health Organization (WHO), cancer ranks as the second most common cause of death globally. This growing burden of chronic diseases is expected to drive expenditure on research and development (R&D) projects aimed at developing effective cell cultures.

Growth in Stem Cell Research and Therapies

Stem cell research continues to expand, and stem cell therapies are gaining popularity. Recombinant cell culture supplements are increasingly used to facilitate the clinical development of cellular therapies, thereby boosting the market.

Why is the Global Recombinant Cell Culture Supplements Market Growing?

Demand for Animal-Free Supplements

The global market for recombinant cell culture supplements is expected to thrive due to the widespread use of animal-free variants in various research applications. Animal-free recombinant cell culture supplements remain uncontaminated, as they are free of animal components like serum, endotoxins, and endogenous mammalian contamination. As consumer demand for these animal-free products increases, manufacturers are focusing on delivering them to the market.

Increasing Demand for Growth Factors in Regenerative Medicine

Growth factors play a crucial role in tissue regeneration, with a high demand for recombinant growth factors in addressing issues such as periodontal problems and diabetic neuropathic ulcers. The demand for recombinant cell culture supplements is projected to grow, driven by the expanding opportunities in gene therapy and regenerative medicine research.

Rise in Life Science Research Funding

The growth of various research projects and the recruitment of new personnel are facilitated by funding for life science research and investments in areas like growth factors, cytokines, and biologics. Multiple sources, including governments, commercial organizations, and private funding, contribute to R&D expenditures.

Country-Wise Insights

U.S.: Government and Academic Efforts Drive Demand

The U.S. market is poised for growth due to increased research and development expenditure. Leading institutions like the National Cancer Institute (NCI) invest in significant research projects, promoting studies related to cancer challenges. Government and academic efforts, along with ongoing oncology research, are expected to boost the demand for recombinant cell culture supplements.

Germany: Presence of Major Players

Germany is likely to witness higher returns in the recombinant cell culture supplements market, driven by the presence of major players such as OLS OMNI Life Science GmbH, Co. Kg, Cytiva Europe GmbH, and Becton, Dickinson and Company. The country's expanding contract research manufacturing and R&D activities will further drive demand.

China: Increasing Drug Discovery and Research

China, known for its rapid technological adoption, leads in drug discovery and research activities. As the demand for drug discovery and research continues to rise, along with China's position as home to one of the world's largest biopharmaceutical sectors, the use of recombinant cell culture supplements is on the rise.

Competitive Landscape

Key Players in the Market

• Merck, KGaA
• Thermo Fisher Scientific
• Lonza Group AG
• F. Hoffmann-La Roche
• Abcam PLC.
• Hi-Media Laboratories
• Becton, Dickinson and Company
• STEMCELL Technologies Inc.
• Fujifilm Corporation
• InVitria
• Biocon
• Cell Sciences, Inc.

Segments of Recombinant Cell Culture Supplements Industry Research

By Product:

• Recombinant Growth Factors

Transforming Growth Factor

Epidermal Growth Factor

Platelet-Derived Growth Factors

Fibroblast Growth Factor

Vascular Endothelial Growth Factors (VEGFs)

Interleukins

Recombinant Stem Cell Factor

Other Growth Factors

• Recombinant Insulin
• Recombinant Albumin
• Recombinant Transferrin
• Recombinant Trypsin
• Recombinant Aprotinin
• Recombinant Lysozyme
• Others

By Application:

• Stem Cell Therapy
• Gene Therapy
• Bioprocess Application
• Vaccine Development
• Others

By Source:

• Animals
• Microorganisms
• Human

By End User:

• Academic and Research Institutes
• Biopharmaceutical Companies
• Cancer Research Centers
• Contract Research Centers (CROs)

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global Recombinant Cell Culture Supplements Market Snapshot
• 1.2. Future Projections
• 1.3. Key Market Trends
• 1.4. Regional Snapshot, by Value, 2023
• 1.5. Analyst Recommendations

2. Market Overview

• 2.1. Market Definitions and Segmentations
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Market Opportunities
• 2.3. Value Chain Analysis
• 2.4. Porter's Five Forces Analysis
• 2.5. COVID-19 Impact Analysis
  • 2.5.1. Supply
  • 2.5.2. Demand
• 2.6. Impact of Ukraine-Russia Conflict
• 2.7. Economic Overview
  • 2.7.1. World Economic Projections
• 2.8. PESTLE Analysis

3. Global Recombinant Cell Culture Supplements Market Outlook, 2018 - 2031

• 3.1. Global Recombinant Cell Culture Supplements Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
  • 3.1.1. Key Highlights
    • 3.1.1.1. Recombinant Growth Factors
      • 3.1.1.1.1. Transforming Growth Factor
      • 3.1.1.1.2. Epidermal Growth Factor
      • 3.1.1.1.3. Platelet-Derived Growth Factors
      • 3.1.1.1.4. Fibroblast Growth Factor
      • 3.1.1.1.5. Vascular Endothelial Growth Factors (VEGFs)
      • 3.1.1.1.6. Interleukins
      • 3.1.1.1.7. Recombinant Stem Cell Factor
      • 3.1.1.1.8. Other Growth Factors
    • 3.1.1.2. Recombinant Insulin
    • 3.1.1.3. Recombinant Albumin
    • 3.1.1.4. Recombinant Transferrin
    • 3.1.1.5. Recombinant Trypsin
    • 3.1.1.6. Recombinant Aprotinin
    • 3.1.1.7. Recombinant Lysozyme
    • 3.1.1.8. Others
• 3.2. Global Recombinant Cell Culture Supplements Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
  • 3.2.1. Key Highlights
    • 3.2.1.1. Stem Cell Therapy
    • 3.2.1.2. Gene Therapy
    • 3.2.1.3. Bioprocess Application
    • 3.2.1.4. Vaccine Development
    • 3.2.1.5. Others
• 3.3. Global Recombinant Cell Culture Supplements Market Outlook, by Source, Value (US$ Mn), 2018 - 2031
  • 3.3.1. Key Highlights
    • 3.3.1.1. Animals
    • 3.3.1.2. Microorganisms
    • 3.3.1.3. Human
• 3.4. Global Recombinant Cell Culture Supplements Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
  • 3.4.1. Key Highlights
    • 3.4.1.1. Academic and Research Institutes
    • 3.4.1.2. Biopharmaceutical Companies
    • 3.4.1.3. Cancer Research Centers
    • 3.4.1.4. Contract Research Centers (CROs)
• 3.5. Global Recombinant Cell Culture Supplements Market Outlook, by Region, Value (US$ Mn), 2018 - 2031
  • 3.5.1. Key Highlights
    • 3.5.1.1. North America
    • 3.5.1.2. Europe
    • 3.5.1.3. Asia Pacific
    • 3.5.1.4. Latin America
    • 3.5.1.5. Middle East & Africa

4. North America Recombinant Cell Culture Supplements Market Outlook, 2018 - 2031

• 4.1. North America Recombinant Cell Culture Supplements Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
  • 4.1.1. Key Highlights
    • 4.1.1.1. Recombinant Growth Factors
      • 4.1.1.1.1. Transforming Growth Factor
      • 4.1.1.1.2. Epidermal Growth Factor
      • 4.1.1.1.3. Platelet-Derived Growth Factors
      • 4.1.1.1.4. Fibroblast Growth Factor
      • 4.1.1.1.5. Vascular Endothelial Growth Factors (VEGFs)
      • 4.1.1.1.6. Interleukins
      • 4.1.1.1.7. Recombinant Stem Cell Factor
      • 4.1.1.1.8. Other Growth Factors
    • 4.1.1.2. Recombinant Insulin
    • 4.1.1.3. Recombinant Albumin
    • 4.1.1.4. Recombinant Transferrin
    • 4.1.1.5. Recombinant Trypsin
    • 4.1.1.6. Recombinant Aprotinin
    • 4.1.1.7. Recombinant Lysozyme
    • 4.1.1.8. Others
• 4.2. North America Recombinant Cell Culture Supplements Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
  • 4.2.1. Key Highlights
    • 4.2.1.1. Stem Cell Therapy
    • 4.2.1.2. Gene Therapy
    • 4.2.1.3. Bioprocess Application
    • 4.2.1.4. Vaccine Development
    • 4.2.1.5. Others
• 4.3. North America Recombinant Cell Culture Supplements Market Outlook, by Source, Value (US$ Mn), 2018 - 2031
  • 4.3.1. Key Highlights
    • 4.3.1.1. Animals
    • 4.3.1.2. Microorganisms
    • 4.3.1.3. Human
• 4.4. North America Recombinant Cell Culture Supplements Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
  • 4.4.1. Key Highlights
    • 4.4.1.1. Academic and Research Institutes
    • 4.4.1.2. Biopharmaceutical Companies
    • 4.4.1.3. Cancer Research Centers
    • 4.4.1.4. Contract Research Centers (CROs)
• 4.5. North America Recombinant Cell Culture Supplements Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
  • 4.5.1. Key Highlights
    • 4.5.1.1. U.S. Recombinant Cell Culture Supplements Market by Product, Value (US$ Mn), 2018 - 2031
    • 4.5.1.2. U.S. Recombinant Cell Culture Supplements Market By Application, Value (US$ Mn), 2018 - 2031
    • 4.5.1.3. U.S. Recombinant Cell Culture Supplements Market By Source, Value (US$ Mn), 2018 - 2031
    • 4.5.1.4. U.S. Recombinant Cell Culture Supplements Market End User, Value (US$ Mn), 2018 - 2031
    • 4.5.1.5. Canada Recombinant Cell Culture Supplements Market by Product, Value (US$ Mn), 2018 - 2031
    • 4.5.1.6. Canada Recombinant Cell Culture Supplements Market By Application, Value (US$ Mn), 2018 - 2031
    • 4.5.1.7. Canada Recombinant Cell Culture Supplements Market By Source, Value (US$ Mn), 2018 - 2031
    • 4.5.1.8. Canada Recombinant Cell Culture Supplements Market End User, Value (US$ Mn), 2018 - 2031
  • 4.5.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Recombinant Cell Culture Supplements Market Outlook, 2018 - 2031

• 5.1. Europe Recombinant Cell Culture Supplements Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
  • 5.1.1. Key Highlights
    • 5.1.1.1. Recombinant Growth Factors
      • 5.1.1.1.1. Transforming Growth Factor
      • 5.1.1.1.2. Epidermal Growth Factor
      • 5.1.1.1.3. Platelet-Derived Growth Factors
      • 5.1.1.1.4. Fibroblast Growth Factor
      • 5.1.1.1.5. Vascular Endothelial Growth Factors (VEGFs)
      • 5.1.1.1.6. Interleukins
      • 5.1.1.1.7. Recombinant Stem Cell Factor
      • 5.1.1.1.8. Other Growth Factors
    • 5.1.1.2. Recombinant Insulin
    • 5.1.1.3. Recombinant Albumin
    • 5.1.1.4. Recombinant Transferrin
    • 5.1.1.5. Recombinant Trypsin
    • 5.1.1.6. Recombinant Aprotinin
    • 5.1.1.7. Recombinant Lysozyme
    • 5.1.1.8. Others
• 5.2. Europe Recombinant Cell Culture Supplements Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
  • 5.2.1. Key Highlights
    • 5.2.1.1. Stem Cell Therapy
    • 5.2.1.2. Gene Therapy
    • 5.2.1.3. Bioprocess Application
    • 5.2.1.4. Vaccine Development
    • 5.2.1.5. Others
• 5.3. Europe Recombinant Cell Culture Supplements Market Outlook, by Source, Value (US$ Mn), 2018 - 2031
  • 5.3.1. Key Highlights
    • 5.3.1.1. Animals
    • 5.3.1.2. Microorganisms
    • 5.3.1.3. Human
• 5.4. Europe Recombinant Cell Culture Supplements Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
  • 5.4.1. Key Highlights
    • 5.4.1.1. Academic and Research Institutes
    • 5.4.1.2. Biopharmaceutical Companies
    • 5.4.1.3. Cancer Research Centers
    • 5.4.1.4. Contract Research Centers (CROs)
• 5.5. Europe Recombinant Cell Culture Supplements Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
  • 5.5.1. Key Highlights
    • 5.5.1.1. Germany Recombinant Cell Culture Supplements Market by Product, Value (US$ Mn), 2018 - 2031
    • 5.5.1.2. Germany Recombinant Cell Culture Supplements Market By Application, Value (US$ Mn), 2018 - 2031
    • 5.5.1.3. Germany Recombinant Cell Culture Supplements Market By Source, Value (US$ Mn), 2018 - 2031
    • 5.5.1.4. Germany Recombinant Cell Culture Supplements Market End User, Value (US$ Mn), 2018 - 2031
    • 5.5.1.5. U.K. Recombinant Cell Culture Supplements Market by Product, Value (US$ Mn), 2018 - 2031
    • 5.5.1.6. U.K. Recombinant Cell Culture Supplements Market By Application, Value (US$ Mn), 2018 - 2031
    • 5.5.1.7. U.K. Recombinant Cell Culture Supplements Market By Source, Value (US$ Mn), 2018 - 2031
    • 5.5.1.8. U.K. Recombinant Cell Culture Supplements Market End User, Value (US$ Mn), 2018 - 2031
    • 5.5.1.9. France Recombinant Cell Culture Supplements Market by Product, Value (US$ Mn), 2018 - 2031
    • 5.5.1.10. France Recombinant Cell Culture Supplements Market By Application, Value (US$ Mn), 2018 - 2031
    • 5.5.1.11. France Recombinant Cell Culture Supplements Market By Source, Value (US$ Mn), 2018 - 2031
    • 5.5.1.12. France Recombinant Cell Culture Supplements Market End User, Value (US$ Mn), 2018 - 2031
    • 5.5.1.13. Italy Recombinant Cell Culture Supplements Market by Product, Value (US$ Mn), 2018 - 2031
    • 5.5.1.14. Italy Recombinant Cell Culture Supplements Market By Application, Value (US$ Mn), 2018 - 2031
    • 5.5.1.15. Italy Recombinant Cell Culture Supplements Market By Source, Value (US$ Mn), 2018 - 2031
    • 5.5.1.16. Italy Recombinant Cell Culture Supplements Market End User, Value (US$ Mn), 2018 - 2031
    • 5.5.1.17. Turkey Recombinant Cell Culture Supplements Market by Product, Value (US$ Mn), 2018 - 2031
    • 5.5.1.18. Turkey Recombinant Cell Culture Supplements Market By Application, Value (US$ Mn), 2018 - 2031
    • 5.5.1.19. Turkey Recombinant Cell Culture Supplements Market By Source, Value (US$ Mn), 2018 - 2031
    • 5.5.1.20. Turkey Recombinant Cell Culture Supplements Market End User, Value (US$ Mn), 2018 - 2031
    • 5.5.1.21. Russia Recombinant Cell Culture Supplements Market by Product, Value (US$ Mn), 2018 - 2031
    • 5.5.1.22. Russia Recombinant Cell Culture Supplements Market By Application, Value (US$ Mn), 2018 - 2031
    • 5.5.1.23. Russia Recombinant Cell Culture Supplements Market By Source, Value (US$ Mn), 2018 - 2031
    • 5.5.1.24. Russia Recombinant Cell Culture Supplements Market End User, Value (US$ Mn), 2018 - 2031
    • 5.5.1.25. Rest of Europe Recombinant Cell Culture Supplements Market by Product, Value (US$ Mn), 2018 - 2031
    • 5.5.1.26. Rest of Europe Recombinant Cell Culture Supplements Market By Application, Value (US$ Mn), 2018 - 2031
    • 5.5.1.27. Rest of Europe Recombinant Cell Culture Supplements Market By Source, Value (US$ Mn), 2018 - 2031
    • 5.5.1.28. Rest of Europe Recombinant Cell Culture Supplements Market End User, Value (US$ Mn), 2018 - 2031
  • 5.5.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Recombinant Cell Culture Supplements Market Outlook, 2018 - 2031

• 6.1. Asia Pacific Recombinant Cell Culture Supplements Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
  • 6.1.1. Key Highlights
    • 6.1.1.1. Recombinant Growth Factors
      • 6.1.1.1.1. Transforming Growth Factor
      • 6.1.1.1.2. Epidermal Growth Factor
      • 6.1.1.1.3. Platelet-Derived Growth Factors
      • 6.1.1.1.4. Fibroblast Growth Factor
      • 6.1.1.1.5. Vascular Endothelial Growth Factors (VEGFs)
      • 6.1.1.1.6. Interleukins
      • 6.1.1.1.7. Recombinant Stem Cell Factor
      • 6.1.1.1.8. Other Growth Factors
    • 6.1.1.2. Recombinant Insulin
    • 6.1.1.3. Recombinant Albumin
    • 6.1.1.4. Recombinant Transferrin
    • 6.1.1.5. Recombinant Trypsin
    • 6.1.1.6. Recombinant Aprotinin
    • 6.1.1.7. Recombinant Lysozyme
    • 6.1.1.8. Others
• 6.2. Asia Pacific Recombinant Cell Culture Supplements Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
  • 6.2.1. Key Highlights
    • 6.2.1.1. Stem Cell Therapy
    • 6.2.1.2. Gene Therapy
    • 6.2.1.3. Bioprocess Application
    • 6.2.1.4. Vaccine Development
    • 6.2.1.5. Others
• 6.3. Asia Pacific Recombinant Cell Culture Supplements Market Outlook, by Source, Value (US$ Mn), 2018 - 2031
  • 6.3.1. Key Highlights
    • 6.3.1.1. Animals
    • 6.3.1.2. Microorganisms
    • 6.3.1.3. Human
• 6.4. Asia Pacific Recombinant Cell Culture Supplements Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
  • 6.4.1. Key Highlights
    • 6.4.1.1. Academic and Research Institutes
    • 6.4.1.2. Biopharmaceutical Companies
    • 6.4.1.3. Cancer Research Centers
    • 6.4.1.4. Contract Research Centers (CROs)
• 6.5. Asia Pacific Recombinant Cell Culture Supplements Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
  • 6.5.1. Key Highlights
    • 6.5.1.1. China Recombinant Cell Culture Supplements Market by Product, Value (US$ Mn), 2018 - 2031
    • 6.5.1.2. China Recombinant Cell Culture Supplements Market By Application, Value (US$ Mn), 2018 - 2031
    • 6.5.1.3. China Recombinant Cell Culture Supplements Market By Source, Value (US$ Mn), 2018 - 2031
    • 6.5.1.4. China Recombinant Cell Culture Supplements Market End User, Value (US$ Mn), 2018 - 2031
    • 6.5.1.5. Japan Recombinant Cell Culture Supplements Market by Product, Value (US$ Mn), 2018 - 2031
    • 6.5.1.6. Japan Recombinant Cell Culture Supplements Market By Application, Value (US$ Mn), 2018 - 2031
    • 6.5.1.7. Japan Recombinant Cell Culture Supplements Market By Source, Value (US$ Mn), 2018 - 2031
    • 6.5.1.8. Japan Recombinant Cell Culture Supplements Market End User, Value (US$ Mn), 2018 - 2031
    • 6.5.1.9. South Korea Recombinant Cell Culture Supplements Market by Product, Value (US$ Mn), 2018 - 2031
    • 6.5.1.10. South Korea Recombinant Cell Culture Supplements Market By Application, Value (US$ Mn), 2018 - 2031
    • 6.5.1.11. South Korea Recombinant Cell Culture Supplements Market By Source, Value (US$ Mn), 2018 - 2031
    • 6.5.1.12. South Korea Recombinant Cell Culture Supplements Market End User, Value (US$ Mn), 2018 - 2031
    • 6.5.1.13. India Recombinant Cell Culture Supplements Market by Product, Value (US$ Mn), 2018 - 2031
    • 6.5.1.14. India Recombinant Cell Culture Supplements Market By Application, Value (US$ Mn), 2018 - 2031
    • 6.5.1.15. India Recombinant Cell Culture Supplements Market By Source, Value (US$ Mn), 2018 - 2031
    • 6.5.1.16. India Recombinant Cell Culture Supplements Market End User, Value (US$ Mn), 2018 - 2031
    • 6.5.1.17. Southeast Asia Recombinant Cell Culture Supplements Market by Product, Value (US$ Mn), 2018 - 2031
    • 6.5.1.18. Southeast Asia Recombinant Cell Culture Supplements Market By Application, Value (US$ Mn), 2018 - 2031
    • 6.5.1.19. Southeast Asia Recombinant Cell Culture Supplements Market By Source, Value (US$ Mn), 2018 - 2031
    • 6.5.1.20. Southeast Asia Recombinant Cell Culture Supplements Market End User, Value (US$ Mn), 2018 - 2031
    • 6.5.1.21. Rest of Asia Pacific Recombinant Cell Culture Supplements Market by Product, Value (US$ Mn), 2018 - 2031
    • 6.5.1.22. Rest of Asia Pacific Recombinant Cell Culture Supplements Market By Application, Value (US$ Mn), 2018 - 2031
    • 6.5.1.23. Rest of Asia Pacific Recombinant Cell Culture Supplements Market By Source, Value (US$ Mn), 2018 - 2031
    • 6.5.1.24. Rest of Asia Pacific Recombinant Cell Culture Supplements Market End User, Value (US$ Mn), 2018 - 2031
  • 6.5.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Recombinant Cell Culture Supplements Market Outlook, 2018 - 2031

• 7.1. Latin America Recombinant Cell Culture Supplements Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
  • 7.1.1. Key Highlights
    • 7.1.1.1. Recombinant Growth Factors
      • 7.1.1.1.1. Transforming Growth Factor
      • 7.1.1.1.2. Epidermal Growth Factor
      • 7.1.1.1.3. Platelet-Derived Growth Factors
      • 7.1.1.1.4. Fibroblast Growth Factor
      • 7.1.1.1.5. Vascular Endothelial Growth Factors (VEGFs)
      • 7.1.1.1.6. Interleukins
      • 7.1.1.1.7. Recombinant Stem Cell Factor
      • 7.1.1.1.8. Other Growth Factors
    • 7.1.1.2. Recombinant Insulin
    • 7.1.1.3. Recombinant Albumin
    • 7.1.1.4. Recombinant Transferrin
    • 7.1.1.5. Recombinant Trypsin
    • 7.1.1.6. Recombinant Aprotinin
    • 7.1.1.7. Recombinant Lysozyme
    • 7.1.1.8. Others
• 7.2. Latin America Recombinant Cell Culture Supplements Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
  • 7.2.1.1. Stem Cell Therapy
  • 7.2.1.2. Gene Therapy
  • 7.2.1.3. Bioprocess Application
  • 7.2.1.4. Vaccine Development
  • 7.2.1.5. Others
• 7.3. Latin America Recombinant Cell Culture Supplements Market Outlook, by Source, Value (US$ Mn), 2018 - 2031
  • 7.3.1. Key Highlights
    • 7.3.1.1. Animals
    • 7.3.1.2. Microorganisms
    • 7.3.1.3. Human
• 7.4. Latin America Recombinant Cell Culture Supplements Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
  • 7.4.1. Key Highlights
    • 7.4.1.1. Academic and Research Institutes
    • 7.4.1.2. Biopharmaceutical Companies
    • 7.4.1.3. Cancer Research Centers
    • 7.4.1.4. Contract Research Centers (CROs)
• 7.5. Latin America Recombinant Cell Culture Supplements Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
  • 7.5.1. Key Highlights
    • 7.5.1.1. Brazil Recombinant Cell Culture Supplements Market by Product, Value (US$ Mn), 2018 - 2031
    • 7.5.1.2. Brazil Recombinant Cell Culture Supplements Market By Application, Value (US$ Mn), 2018 - 2031
    • 7.5.1.3. Brazil Recombinant Cell Culture Supplements Market By Source, Value (US$ Mn), 2018 - 2031
    • 7.5.1.4. Brazil Recombinant Cell Culture Supplements Market End User, Value (US$ Mn), 2018 - 2031
    • 7.5.1.5. Mexico Recombinant Cell Culture Supplements Market by Product, Value (US$ Mn), 2018 - 2031
    • 7.5.1.6. Mexico Recombinant Cell Culture Supplements Market By Application, Value (US$ Mn), 2018 - 2031
    • 7.5.1.7. Mexico Recombinant Cell Culture Supplements Market By Source, Value (US$ Mn), 2018 - 2031
    • 7.5.1.8. Mexico Recombinant Cell Culture Supplements Market End User, Value (US$ Mn), 2018 - 2031
    • 7.5.1.9. Argentina Recombinant Cell Culture Supplements Market by Product, Value (US$ Mn), 2018 - 2031
    • 7.5.1.10. Argentina Recombinant Cell Culture Supplements Market By Application, Value (US$ Mn), 2018 - 2031
    • 7.5.1.11. Argentina Recombinant Cell Culture Supplements Market By Source, Value (US$ Mn), 2018 - 2031
    • 7.5.1.12. Argentina Recombinant Cell Culture Supplements Market End User, Value (US$ Mn), 2018 - 2031
    • 7.5.1.13. Rest of Latin America Recombinant Cell Culture Supplements Market by Product, Value (US$ Mn), 2018 - 2031
    • 7.5.1.14. Rest of Latin America Recombinant Cell Culture Supplements Market By Application, Value (US$ Mn), 2018 - 2031
    • 7.5.1.15. Rest of Latin America Recombinant Cell Culture Supplements Market By Source, Value (US$ Mn), 2018 - 2031
    • 7.5.1.16. Rest of Latin America Recombinant Cell Culture Supplements Market End User, Value (US$ Mn), 2018 - 2031
  • 7.5.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Recombinant Cell Culture Supplements Market Outlook, 2018 - 2031

• 8.1. Middle East & Africa Recombinant Cell Culture Supplements Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
  • 8.1.1. Key Highlights
    • 8.1.1.1. Recombinant Growth Factors
      • 8.1.1.1.1. Transforming Growth Factor
      • 8.1.1.1.2. Epidermal Growth Factor
      • 8.1.1.1.3. Platelet-Derived Growth Factors
      • 8.1.1.1.4. Fibroblast Growth Factor
      • 8.1.1.1.5. Vascular Endothelial Growth Factors (VEGFs)
      • 8.1.1.1.6. Interleukins
      • 8.1.1.1.7. Recombinant Stem Cell Factor
      • 8.1.1.1.8. Other Growth Factors
    • 8.1.1.2. Recombinant Insulin
    • 8.1.1.3. Recombinant Albumin
    • 8.1.1.4. Recombinant Transferrin
    • 8.1.1.5. Recombinant Trypsin
    • 8.1.1.6. Recombinant Aprotinin
    • 8.1.1.7. Recombinant Lysozyme
    • 8.1.1.8. Others
• 8.2. Middle East & Africa Recombinant Cell Culture Supplements Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
  • 8.2.1. Key Highlights
    • 8.2.1.1. Stem Cell Therapy
    • 8.2.1.2. Gene Therapy
    • 8.2.1.3. Bioprocess Application
    • 8.2.1.4. Vaccine Development
    • 8.2.1.5. Others
• 8.3. Middle East & Africa Recombinant Cell Culture Supplements Market Outlook, by Source, Value (US$ Mn), 2018 - 2031
  • 8.3.1. Key Highlights
    • 8.3.1.1. Animals
    • 8.3.1.2. Microorganisms
    • 8.3.1.3. Human
• 8.4. Middle East & Africa Recombinant Cell Culture Supplements Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
  • 8.4.1. Key Highlights
    • 8.4.1.1. Academic and Research Institutes
    • 8.4.1.2. Biopharmaceutical Companies
    • 8.4.1.3. Cancer Research Centers
    • 8.4.1.4. Contract Research Centers (CROs)
• 8.5. Middle East & Africa Recombinant Cell Culture Supplements Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
  • 8.5.1. Key Highlights
    • 8.5.1.1. GCC Recombinant Cell Culture Supplements Market by Product, Value (US$ Mn), 2018 - 2031
    • 8.5.1.2. GCC Recombinant Cell Culture Supplements Market By Application, Value (US$ Mn), 2018 - 2031
    • 8.5.1.3. GCC Recombinant Cell Culture Supplements Market By Source, Value (US$ Mn), 2018 - 2031
    • 8.5.1.4. GCC Recombinant Cell Culture Supplements Market End User, Value (US$ Mn), 2018 - 2031
    • 8.5.1.5. South Africa Recombinant Cell Culture Supplements Market by Product, Value (US$ Mn), 2018 - 2031
    • 8.5.1.6. South Africa Recombinant Cell Culture Supplements Market By Application, Value (US$ Mn), 2018 - 2031
    • 8.5.1.7. South Africa Recombinant Cell Culture Supplements Market By Source, Value (US$ Mn), 2018 - 2031
    • 8.5.1.8. South Africa Recombinant Cell Culture Supplements Market End User, Value (US$ Mn), 2018 - 2031
    • 8.5.1.9. Egypt Recombinant Cell Culture Supplements Market by Product, Value (US$ Mn), 2018 - 2031
    • 8.5.1.10. Egypt Recombinant Cell Culture Supplements Market By Application, Value (US$ Mn), 2018 - 2031
    • 8.5.1.11. Egypt Recombinant Cell Culture Supplements Market By Source, Value (US$ Mn), 2018 - 2031
    • 8.5.1.12. Egypt Recombinant Cell Culture Supplements Market End User, Value (US$ Mn), 2018 - 2031
    • 8.5.1.13. Nigeria Recombinant Cell Culture Supplements Market by Product, Value (US$ Mn), 2018 - 2031
    • 8.5.1.14. Nigeria Recombinant Cell Culture Supplements Market By Application, Value (US$ Mn), 2018 - 2031
    • 8.5.1.15. Nigeria Recombinant Cell Culture Supplements Market By Source, Value (US$ Mn), 2018 - 2031
    • 8.5.1.16. Nigeria Recombinant Cell Culture Supplements Market End User, Value (US$ Mn), 2018 - 2031
    • 8.5.1.17. Rest of Middle East & Africa Recombinant Cell Culture Supplements Market by Product, Value (US$ Mn), 2018 - 2031
    • 8.5.1.18. Rest of Middle East & Africa Recombinant Cell Culture Supplements Market By Application, Value (US$ Mn), 2018 - 2031
    • 8.5.1.19. Rest of Middle East & Africa Recombinant Cell Culture Supplements Market By Source, Value (US$ Mn), 2018 - 2031
    • 8.5.1.20. Rest of Middle East & Africa Recombinant Cell Culture Supplements Market End User, Value (US$ Mn), 2018 - 2031
  • 8.5.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

• 9.1. By Source vs By Application Heatmap
• 9.2. Manufacturer vs By Application Heatmap
• 9.3. Company Market Share Analysis, 2023
• 9.4. Competitive Dashboard
• 9.5. Company Profiles
  • 9.5.1. Merck, KGaA
    • 9.5.1.1. Company Overview
    • 9.5.1.2. Product Portfolio
    • 9.5.1.3. Financial Overview
    • 9.5.1.4. Business Strategies and Development
  • 9.5.2. Thermo Fisher Scientific
    • 9.5.2.1. Company Overview
    • 9.5.2.2. Product Portfolio
    • 9.5.2.3. Financial Overview
    • 9.5.2.4. Business Strategies and Development
  • 9.5.3. Lonza Group AG
    • 9.5.3.1. Company Overview
    • 9.5.3.2. Product Portfolio
    • 9.5.3.3. Financial Overview
    • 9.5.3.4. Business Strategies and Development
  • 9.5.4. F. Hoffmann-La Roche
    • 9.5.4.1. Company Overview
    • 9.5.4.2. Product Portfolio
    • 9.5.4.3. Financial Overview
    • 9.5.4.4. Business Strategies and Development
  • 9.5.5. Abcam PLC.
    • 9.5.5.1. Company Overview
    • 9.5.5.2. Product Portfolio
    • 9.5.5.3. Financial Overview
    • 9.5.5.4. Business Strategies and Development
  • 9.5.6. Hi-Media Laboratories
    • 9.5.6.1. Company Overview
    • 9.5.6.2. Product Portfolio
    • 9.5.6.3. Financial Overview
    • 9.5.6.4. Business Strategies and Development
  • 9.5.7. Becton, Dickinson and Company
    • 9.5.7.1. Company Overview
    • 9.5.7.2. Product Portfolio
    • 9.5.7.3. Financial Overview
    • 9.5.7.4. Business Strategies and Development
  • 9.5.8. Fujifilm Corporation
    • 9.5.8.1. Company Overview
    • 9.5.8.2. Product Portfolio
    • 9.5.8.3. Financial Overview
    • 9.5.8.4. Business Strategies and Development
  • 9.5.9. STEMCELL Technologies Inc.
    • 9.5.9.1. Company Overview
    • 9.5.9.2. Product Portfolio
    • 9.5.9.3. Financial Overview
    • 9.5.9.4. Business Strategies and Development
  • 9.5.10. InVitria
    • 9.5.10.1. Company Overview
    • 9.5.10.2. Product Portfolio
    • 9.5.10.3. Financial Overview
    • 9.5.10.4. Business Strategies and Development
  • 9.5.11. Biocon
    • 9.5.11.1. Company Overview
    • 9.5.11.2. Product Portfolio
    • 9.5.11.3. Financial Overview
    • 9.5.11.4. Business Strategies and Development
  • 9.5.12. Cell Sciences, Inc.
    • 9.5.12.1. Company Overview
    • 9.5.12.2. Product Portfolio
    • 9.5.12.3. Financial Overview
    • 9.5.12.4. Business Strategies and Development

10. Appendix

• 10.1. Research Methodology
• 10.2. Report Assumptions
• 10.3. Acronyms and Abbreviations

관련자료